The Patent Finder

Leica Biosystems Melbourne Pty Ltd.

58 patents currently held · Updated Nov 19, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

10
Ending by 2030
Jul 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 30, 2026
    The maintenance fee for Reagent system and method (US 9,068,989) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
  • 1 fee due Apr 22, 2027
    The maintenance fee for Device and method for cross-referencing (US 10,453,564) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
  • 1 fee due Jul 12, 2027
    The maintenance fee for Method and apparatus for handling tissue samples (US 9,234,823) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Cover member, method and treatment module for treating a biological sample on a substrate (US 10,549,271) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 2 fees due Sep 3 to 26, 2027 · next Sep 3

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 21, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,315,899Method of scheduling
In force
 · USPTO record
In forceUSPTO record
US 8,554,372System and method for histological tissue specimen processing
In force
 · USPTO record
In forceUSPTO record
US 9,346,053Method and apparatus for fluid dispensation, preparation and dilution
In force
 · USPTO record
In forceUSPTO record
US 8,396,669Analysis system and procedures
In force
 · USPTO record
In forceUSPTO record
US 10,453,564Device and method for cross-referencing
In force
 · USPTO record
In forceUSPTO record
US 8,409,871Method of treatment of tissue processing fluid and apparatus therefor
In force
 · USPTO record
In forceUSPTO record
US 8,758,707Staining instruments and methods
In force
 · USPTO record
In forceUSPTO record
US 9,691,043Device and method for cross-referencing
In force
 · USPTO record
In forceUSPTO record
US 9,234,823Method and apparatus for handling tissue samples
In force
 · USPTO record
In forceUSPTO record
US 8,673,588Composition and method for handling tissue samples
In force
 · USPTO record
In forceUSPTO record
10 of 58 patents shown.
Pro members see all 58.
Pro members: see all 58 patents
Also on record, not counted in the 58: 2 patents in force now held by others · 10 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 abandoned · 6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited